Sovereign compute, free for 30 days
DGX Dev Pod sandbox accounts, priority scheduling, segregated Canadian pods. No compute charge during the proof sprint.
This is the offer on the table for the first cohort. Commercial specifics are settled at Stage 3 and written into a term sheet — not implied by a landing page.
DGX Dev Pod sandbox accounts, priority scheduling, segregated Canadian pods. No compute charge during the proof sprint.
Twelve agents, the Assure SDK, reference connectors and 150+ MCP integrations. Skip months of orchestration, audit and RBAC plumbing.
Access to the wider engineering organisation, QA, cloud and security review, and a joint squad from day 60.
Co-branded evidence packs mapped to Law 25, PIPEDA, ISO/IEC 42001 and AIUC-1, plus a mark once your product passes the gates.
Warm paths into CIOs, reference customers, a 1,000+ member business alliance and public-sector routes.
Co-branded sandbox, CIO roundtables, co-selling playbooks and joint public-sector bids with mutual approval on every announcement.
Design input on identity, A2A trust, commerce, voice, clinical and physical AI before they are generally available.
Pre-existing IP stays yours. Separate repositories, contributor licences, mutual NDA and a clean-exit handover.
Structure is chosen at Stage 3, once there is evidence on the table. Not before.
You introduce, we deliver, you earn. No new entity, fastest to start.
You own the customer relationship and the first line of support.
A shared build with explicit IP boundaries, run through a Canadian entity so joint R&D can be scoped for Canadian programmes.
Aligned upside with governance and a joint roadmap.
A deeper combination for founders building the category rather than a feature.
Pre-existing IP stays with its owner. Joint components are defined in the term sheet, not assumed. A clean-exit handover is part of the agreement, not a favour.
A trust company that overclaims is a contradiction. This is the line we hold ourselves to in public, and it applies to your co-branded material too.
What is a founder position, what is verified, and where the evidence lives.
Thirty minutes, five questions, a written summary either way.